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To  support  sustained  T  cell  produc-
tion, the thymus depends on a supply 
of thymic progenitor cells (TPCs) ar-
riving via the blood. TPCs settle the 
thymus in waves separated by multiple 
weeks (1). This has led to the fascinat-
ing concept that precursor immigration 
to the thymus is “gated.” One clue to 
how thymic gating occurs came from 
the finding that mice lacking IL-7R, 
which have dramatically reduced cell 
numbers in the thymus, had a marked 
increase  in  receptivity  for  settling  by 
transferred  precursors  (2).  Thus,  gate 
opening is promoted when TPC num-
bers are low. But how gate opening is 
regulated remains a mystery. On page 
761  of  this  issue,  Gossens  et  al.  (3)   
report  on  important  new  findings 
that identify additional factors that in-
fluence thymic gating and precursor 
immigration.
Immigration requirements: P-selectin 
ligand and CCR9
It is estimated that as few as 10 TPCs 
settle the mouse thymus per day (4). 
These  cells  give  rise  to  early  thymic 
progenitors  (ETPs;  characterized  as 
Lin
CD44
+CD25
CD117
+ cells) that 
progress  though  the  CD4  and  CD8 
double-negative  (DN)  stages  (DN2, 
DN3, and DN4) of development over 
a period of 2 wk before becoming 
double-positive (DP) cells and, eventu-
ally, CD4 or CD8 single-positive (SP) 
T cells (4). Recent studies have shown 
that both P-selectin and CCR9 are re-
quired for TPCs to enter the thymus 
(4). Mice lacking these molecules have 
fewer immature cells in the thymus, yet 
generate normal numbers of DP and SP 
thymocytes, suggesting that additional 
undefined molecules also mediate TPC 
homing. P-selectin is expressed by thy-
mic vessels (5), most likely in venules 
(6), and P-selectin glycoprotein ligand-
1 (PSGL-1) is its only defined ligand. 
The P-selectin binding site on PSGL-1 
is made up in part by core-2-O–linked 
sugars (7), and cells deficient in core 
2  b1,6-glucosaminyltransferase-I  (C2) 
suffer a partial impairment in P-selec-
tin–dependent rolling (7). The CCR9 
ligand CCL25 (TECK) is expressed by 
thymic  endothelial  cells  and  medul-
lary and cortical epithelial cells (3, 8). 
Although the phenotype of TPCs re-
mains a matter of debate, the emerg-
ing consensus is that they express both 
PSGL-1 and CCR9 (4, 9).
Periodicity in P-selectin  
and CCL25 expression
The study by Gossens et al. (3) begins 
with the authors’ previous finding that 
IL-7R–deficient mice have elevated P-
selectin  expression  on  thymic  vessels 
(5). To further explore the correlation 
between niche occupancy and expres-
sion  of  molecules  needed  for  TPC 
homing,  the  authors  examined  mice 
deficient  in  P-selectin,  PSGL-1,  and 
C2.  Using  intrathymic  injection  of 
bone  marrow  cells  to  measure  niche 
occupancy,  they  find  that  all  three 
strains  have  increased  availability  of 
thymic niche space (3). Findings in IL-
7R
/ mice suggested that DN3 num-
bers  controlled  niche  availability  (2), 
but  no  alterations  in  DN3  numbers 
were seen in the three trafficking mu-
tants in this study. Instead, there was a 
correlation  between  receptivity  and 
endogenous ETP numbers in the thy-
mus. Thus, the number of ETPs (or a 
subset within this compartment) may 
control  intrathymic  niche  availability 
for incoming thymic precursors.
Supporting  a  positive  relationship 
between niche occupancy and P-selec-
tin  expression,  PSGL-1
/  mice  had 
increased levels of P-selectin transcripts 
and  protein,  approaching  the  levels 
seen in IL-7R
/ mice. Unexpectedly, 
however,  C2-deficient  mice  showed 
minimal increases in P-selectin (3). A 
second thymic homing factor, CCL25, 
was  also  increased  in  IL-7R–  and 
PSGL-1–deficient  (but  not  C2-defi-
cient) thymi. In short-term homing as-
says  with  wild-type  cells,  homing  to 
the  thymus  was  increased  in  PSGL-
1
/ recipients, but was not apprecia-
bly  increased  in  C2
/  recipients, 
which is congruent with the P-selectin 
and CCL25 expression data. Thus, the 
relationship between thymic progeni-
tor  niche  occupancy  and  endothelial 
homing  molecule  expression  seemed 
to hold up for PSGL-1–deficient mice, 
but not for C2-deficient mice.
With  two  thymic  homing  mole-
cules  apparently  responding  to  niche 
occupancy signals, Gossens et al. asked 
whether  the  periodicity  of  thymic 
gating could be associated with a peri-
odicity in homing molecule expres-
sion. Remarkably, P-selectin transcript 
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S1P source have normal thymic egress 
(13). S1P produced by a radiation-resis-
tant source is more potent than RBC-
derived S1P in promoting egress (13), 
and  it  will  be  interesting  to  explore 
whether the former source is affected 
by PSGL-1 deficiency.
Although the significance of the re-
duced plasma S1P in PSGL-1–deficient 
mice is not yet clear, it prompted the 
authors to make a potentially important 
connection.  Endothelial  cells  express 
multiple  S1P  receptors,  and  S1P  has 
been shown to augment P-selectin ex-
pression in vitro (3, 14). The authors 
pursued  this  relationship  in  vivo  and 
discovered a correlation between S1P 
plasma abundance and thymic P-selec-
tin  mRNA  levels  in  wild-type  mice. 
Moreover, 3 d of treatment with the 
S1P  agonist  FTY720,  which  blocks 
thymic egress, lead to a reduction in 
P-selectin  mRNA  levels.  P-selectin 
mRNA levels also decreased when S1P 
lyase was inhibited, increasing thymic 
S1P levels to amounts previously shown 
to decrease thymocyte S1P1 expression 
(12).  Both  of  these  treatments  may 
cause desensitization (or degradation) of 
S1P receptors—perhaps those basolat-
erally exposed on endothelial cells—and 
thus  reduce  S1P-mediated  P-selectin 
induction (Fig. 2). Future studies will 
need to explore the specific S1P recep-
tors involved and whether the action 
is directly on the endothelial cell or   
at another site. Because P-selectin is 
to PSGL-1
/ mice, thymic P-selectin 
mRNA levels dropped twofold in 2 d 
and receptivity for thymic settling was 
correspondingly diminished. Recipro-
cally, when peripheral CD4 and CD8 T 
cells were depleted for 24 h in wild-type 
mice, P-selectin expression and precur-
sor receptivity increased. These results 
raise the exciting possibility that thymic 
receptivity for precursors is responsive 
to the peripheral demand for T cells. 
But how do alterations in peripheral T 
cell numbers alter thymic P-selectin ex-
pression? Here, Gossens et al. (3) find 
evidence  for  an  unexpected  link  be-
tween  sphingosine-1-phosphate  (S1P) 
and thymic precursor immigration.
The current model for thymic egress 
posits that after SP thymocytes up-reg-
ulate S1P receptor-1 (S1P1), they en-
counter S1P associated with the blood 
vasculature  and  are  triggered  to  emi-
grate (10). S1P is abundant in the blood 
and is kept low within the thymus by 
the action of S1P lyase (12). Using an 
internally standardized mass spectrome-
try assay, Gossens et al. measured the 
abundance  of  S1P  in  the  blood  and 
found a small but apparently significant 
reduction  of  S1P  (20%)  in  PSGL-
1
/  mice  compared  with  wild-type 
mice—a  reduction  that  is  unlikely  to 
cause an egress defect. P-selectin–defi-
cient mice, on the other hand, had in-
creased plasma S1P (3). Red blood cells 
(RBCs)  are  the  source  of  90%  of 
blood S1P, and yet mice lacking this 
abundance oscillated in the adult thy-
mus  with  a  periodicity  of  2  wk. 
CCL25  oscillated  to  a  lesser  extent, 
perhaps reflecting its more widespread 
expression in the thymus, but a correla-
tion was observed between periods of 
high  P-selectin  and  high  CCL25  ex-
pression.  These  oscillations  were  less 
evident in PSGL-1– and C2-deficient 
mice,  suggesting  a  negative  link  be-
tween the extent of niche occupancy 
and  the  propensity  for  oscillations  to 
occur.  Thus,  the  periodic  filling  and 
emptying of thymic niches may induce 
a  corresponding  change  in  P-selectin 
and CCL25 expression, which rise in 
occurence when the niches are empty 
and  new  precursors  are  needed,  and 
then fall off once the niches are filled 
(Fig.  1).  Future  studies  will  need  to 
quantitate ETP numbers in parallel with 
assessment  of  P-selectin  and  CCL25 
protein abundance to more definitively 
establish this relationship.
Periphery-thymus cross talk via S1P
The authors next tried to find an expla-
nation for the fact that ETP numbers 
were similarly reduced in PSGL-1
/ 
and C2
/ mice, despite the larger ele-
vation in homing molecule expression 
in the PSGL-1
/ mice. A close look at 
the thymic subsets in PSGL-1
/ mice 
revealed an increase in the frequency of 
semimature (also called immature) SP 
cells and mature SP cells. This finding, 
along with the twofold decrease in cir-
culating T cells in the periphery, sug-
gested a possible thymic egress defect. 
SP thymocytes did not accumulate in 
the C2-deficient mice. The accumula-
tion of thymocytes at the semimature 
SP stage is unusual for a thymic egress 
defect,  as  other  strains  of  mice  with 
egress  defects  selectively  accumulate 
mature SP cells (10, 11). However, two 
additional approaches (intrathymic FITC 
injection and T cell receptor excision 
circle  analysis)  supported  the  authors’ 
claim that egress is affected.
The authors suspected that the de-
creased  number  of  circulating  blood 
cells seen in the PSGL-1–deficient mice 
somehow facilitated the induction of P-
selectin. Indeed, when 20 million lym-
phocytes were intravenously injected in 
Figure 1.  Model to explain how niche occupancy by ETPs affects endothelial P-selectin and 
CCL25 expression. When the thymic niche is occupied (left), a signal generated by ETPs or niche 
cells inhibits P-selectin and CCL25 expression by the endothelium. Over a period of 2 wk, some ETP 
niches become vacant, relieving the inhibitory signal and leading to increased P-selectin and CCL25 
expression (right). TPCs are then able to home into the thymus and give rise to ETPs, restarting the 
“clock.” Alternatively, when a niche is empty, niche cells may release a factor that promotes endothe-
lial P-selectin and CCL25 expression and is consumed by ETPs.JEM VOL. 206, April 13, 2009 733
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degradation, but this explanation does 
not  readily  fit  with  the  finding  that 
Rag1
/  and  IL-7R
/  mice  have 
normal amounts of plasma S1P (3, 13). 
Perhaps lymphocyte transfers and de-
pletion treatments cause fluctuations in 
a  cell  type  or  cytokine  that  in  turn 
modulates S1P production or degrada-
tion. Another conundrum is that blood 
S1P is present at micromolar concen-
trations, yet S1P receptors have nano-
molar affinities (19). How could small 
(20–30%) changes in plasma S1P lead 
to alterations in endothelial behavior? 
Most S1P in the blood is bound to   
albumen  or  HDL  and  may  not  be 
bioavailable.  Is  it  possible  that  the 
bioavailable  amounts  of  plasma  S1P 
fluctuate  within  a  meaningful  range? 
The finding that S1P1 surface expres-
sion on blood T cells is fully down-
modulated even in mice with 5–10% 
of normal plasma S1P makes this un-
likely (13). Perhaps the S1P elevations 
saturate degradation systems that nor-
mally keep tissue concentrations low, 
and this allows increased access of S1P 
to ablumenally distributed S1P recep-
tors (Fig. 2). Or maybe the changes in 
plasma  S1P  are  indirect  readouts  of 
more  relevant  local  changes  in  S1P 
production  by  radiation-resistant  cell 
types  (perhaps  endothelial  cells). 
Clearly, much more work is needed, 
but  the  study  by  Gossens  et  al.  (3) 
highlights  the  need  to  consider  the 
physiological correlates of even small 
changes in plasma S1P.
Finally, we come back to the initial 
puzzle of why PSGL-1 deficiency, but 
not  C2  deficiency,  causes  marked   
elevations  in  thymic  P-selectin  ex-
pression.  Despite  the  many  studies 
dedicated to this issue, the explanation 
for  this  discrepancy  remains  unclear. 
The deficiency in circulating T cells in 
PSGL-1
/ mice seems to play a role, 
as  transferring  in  large  numbers  of 
lymphocytes  decreases  P-selectin  ex-
pression. Perhaps the presence of trans-
ferred  PSGL-1
+  cells  in  the  mice 
compensates for a missing signal. Cer-
tainly,  a  variety  of  experiments  can 
now be planned to better define where 
PSGL-1 acts to control thymic P-se-
lectin expression.
opens up many new questions. For ex-
ample, how is the periodic P-selectin 
expression  achieved?  This  study  and 
earlier work suggests that maturation of 
the limited pool of ETPs is involved, 
but how niche emptying triggers eleva-
tions in endothelial P-selectin is not yet 
defined. One study showed that Egr1 is 
needed in the ETP to efficiently deliver 
this signal (15). The role of PSGL-1 in 
thymocyte  maturation  and  how  it   
affects thymic egress is also unclear. 
PSGL-1 promotes T cell migration to-
ward the CCR7 ligand CCL21 by en-
hancing  chemokine  binding  (16), 
raising the question of whether it mod-
ulates responsiveness to S1P in a similar 
way. And how does PSGL-1 deficiency 
cause a reduction in plasma S1P abun-
dance? This is especially perplexing in 
the context of the finding that periph-
eral lymphocyte depletion was other-
wise  associated  with  an  increase  in 
plasma S1P. The S1P elevation seen in 
P-selectin–deficient mice may well fit 
with data showing that P-selectin defi-
ciency causes an increase in circulating 
HDL, given that HDL carry plasma S1P 
(17, 18). However, a relationship be-
tween PSGL-1 and HDL has not been 
reported.
Why does lymphocyte transfer re-
duce plasma S1P and lymphocyte de-
pletion increase it? A straightforward 
argument  is  that  lymphocytes  are  a 
major  compartment  for  plasma  S1P 
expressed by venules in most tissues, it 
will be important to determine if its ex-
pression is also modulated in other vas-
cular beds.
Exploring whether alterations in cir-
culating lymphocyte number might in-
fluence thymic P-selectin expression 
by altering S1P abundance, the authors 
found that S1P was elevated in plasma 
of T cell–depleted mice (contrary to 
what  happens  in  the  lymphopenic 
PSGL-1
/ mice). Reciprocally, when 
T or B cells were infused into PSGL-
1
/ mice, the S1P concentration was 
further reduced (3). In these cases, the 
small increases or decreases in plasma 
S1P  are  concordant  with  the  corre-
sponding changes in thymic P-selectin 
expression (Fig. 2).
Ongoing interrogations at the border
In summary, the study by Gossens et al. 
(3) suggests that oscillating thymic ex-
pression of P-selectin and CCL25 may 
contribute to thymic gating. The new 
data reveal a possible role for PSGL-1 in 
thymic egress and provide evidence for 
an in vivo relationship between plasma 
S1P abundance and thymic P-selectin 
expression.  This  work  not  only  pro-
vides insights into factors regulating 
thymic  precursor  immigration,  it  also 
has implications for understanding the 
interplay between S1P and the vascular 
system. However, the work also leaves 
us  with  some  unresolved  issues  and 
Figure 2.  Model for how changes in plasma S1P affect the expression of P-selectin by 
thymic endothelium. The micromolar concentrations of S1P in plasma may continuously saturate 
luminal S1P receptors (left), but small increases in plasma S1P (or local changes in S1P production 
by endothelial cells) may increase the engagement of receptors on the ablumenal side of the 
enodothelium, where S1P concentrations are low, leading to changes in expression of genes such 
as P-selectin (right).734 SETTLING THE THYMUS | Cyster
The authors leave us with the im-
portant concept that reductions in pe-
ripheral  T  cell  numbers  can  lead  to 
elevations in the expression of thymic 
homing molecules. Future analyses will 
help  to  determine  whether  the  lym-
phopenia that can occur after viral in-
fection or in other diseases is associated 
with  elevations  in  thymic  P-selectin 
and CCL25 expression and receptivity 
for TPCs.
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